Corigliano B E, Appleman M D, Heseltine P N, Leedom J M
Diagn Microbiol Infect Dis. 1984 Apr;2(2):101-6. doi: 10.1016/0732-8893(84)90004-x.
The in vitro activity of norfloxacin (MK-0366), a new oral antimicrobial agent, was compared to that of ampicillin, tetracycline, cefazolin, nitrofurantoin, nalidixic acid, and trimethoprim against 199 gram-negative urinary isolates. Among these isolates were ampicillin-resistant Escherichia coli and gentamicin-resistant Pseudomonas aeruginosa and Serratia marcescens. Norfloxacin was the most active antimicrobial agent tested against all isolates studied; it was the only agent active against P. aeruginosa and S. marcescens.
将新型口服抗菌剂诺氟沙星(MK - 0366)的体外活性与氨苄西林、四环素、头孢唑林、呋喃妥因、萘啶酸和甲氧苄啶针对199株革兰氏阴性尿分离株的活性进行了比较。这些分离株中包括耐氨苄西林的大肠杆菌以及耐庆大霉素的铜绿假单胞菌和粘质沙雷氏菌。诺氟沙星是所测试的针对所有研究分离株活性最强的抗菌剂;它是唯一对铜绿假单胞菌和粘质沙雷氏菌有活性的药物。